» Articles » PMID: 37731041

Remnant Liver Function is Associated with Long-term Survival in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy

Overview
Journal Sci Rep
Specialty Science
Date 2023 Sep 21
PMID 37731041
Authors
Affiliations
Soon will be listed here.
Abstract

It is important to assess the prognosis and intervene before and after surgery in patients with hepatocellular carcinoma. This study aims to elucidate the association of outcomes and residual liver function after hepatectomy. A total of 176 patients who underwent the initial resection for hepatocellular carcinoma between January 2011 and March 2021 at Jichi Medical University were included. Hepatic clearance of the remnant liver was measured using 99mTc-galactosyl serum albumin scintigraphy. The log-rank test was used to analyze survival using the Kaplan-Meier method. Hazard ratios (HR) and 95% confidence intervals (CI) for overall survival were calculated using Cox's proportional hazard model. In multivariate analysis, microvascular invasion, intraoperative blood loss, and hepatic clearance of the remnant liver were independently associated with overall survival. Hepatic clearance of the remnant liver was independently associated with recurrence free survival. This is the first report to show that lower residual liver function is associated with shorter survival in patients with hepatocellular carcinoma undergoing hepatectomy. Preoperative determination of remnant liver function may allow assessment of prognosis in patients planned to undergo resection of hepatocellular carcinoma. Preservation of liver functional reserve may be crucial for improved long-term outcomes after hepatectomy.

Citing Articles

Low functional liver imaging score is associated with poor prognosis following hepatectomy for hepatocellular carcinoma.

Sakai N, Takayashiki T, Takano S, Suzuki D, Ohtsuka M Sci Rep. 2024; 14(1):31290.

PMID: 39732922 PMC: 11682446. DOI: 10.1038/s41598-024-82741-9.

References
1.
Forner A, Reig M, Bruix J . Hepatocellular carcinoma. Lancet. 2018; 391(10127):1301-1314. DOI: 10.1016/S0140-6736(18)30010-2. View

2.
Rahbari N, Mehrabi A, Mollberg N, Muller S, Koch M, Buchler M . Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 2011; 253(3):453-69. DOI: 10.1097/SLA.0b013e31820d944f. View

3.
Naito S, Imamura H, Tukada A, Matsuyama Y, Yoshimoto J, Sugo H . Postoperative recurrence pattern and prognosis of patients with hepatocellular carcinoma, with particular reference to the hepatitis viral infection status. Liver Int. 2013; 34(5):802-13. DOI: 10.1111/liv.12447. View

4.
Kurokawa T, Yamazaki S, Mitsuka Y, Moriguchi M, Sugitani M, Takayama T . Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin. Br J Cancer. 2015; 114(1):53-8. PMC: 4716541. DOI: 10.1038/bjc.2015.423. View

5.
Hiraoka A, Kumada T, Tsuji K, Takaguchi K, Itobayashi E, Kariyama K . Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis. Liver Cancer. 2019; 8(2):121-129. PMC: 6465715. DOI: 10.1159/000488778. View